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Ramsey A. Saleem,1 Sharmila Banerjee-Basu,3 Fred B. Berry,2 Andreas D. Baxevanis,3 and
Michael A. Walter1,2
Departments of 1Medical Genetics and 2Ophthalmology, University of Alberta, Edmonton, Alberta, Canada; and 3Genome Technology
Branch, National Human Genome Research Institute, National Institutes of Health, Besthesda
Five missense mutations of the winged-helix FOXC1 transcription factor, found in patients with Axenfeld-Rieger
(AR) malformations, were investigated for their effects on FOXC1 structure and function. Molecular modeling of
the FOXC1 forkhead domain predicted that the missense mutations did not alter FOXC1 structure. Biochemical
analyses indicated that, whereas all mutant proteins correctly localize to the cell nucleus, the I87Mmutation reduced
FOXC1-protein levels. DNA-binding experiments revealed that, although the S82T and S131L mutations decreased
DNA binding, the F112S and I126M mutations did not. However, the F112S and I126M mutations decrease the
transactivation ability of FOXC1. All the FOXC1 mutations had the net effect of reducing FOXC1 transactivation
ability. These results indicate that the FOXC1 forkhead domain contains separable DNA-binding and transactivation
functions. In addition, these findings demonstrate that reduced stability, DNA binding, or transactivation, all causing
a decrease in the ability of FOXC1 to transactivate genes, can underlie AR malformations.
Introduction
The forkhead/winged-helix family of transcription fac-
tors is required for a variety of developmental processes,
including embryogenesis and tissue-specific cell differ-
entiation, as well as for other biologically important
events, such as tumorigenesis (Kaufmann and Knochel
1996). These transcription factors contain a monomeric,
110-amino-acid DNA-binding domain, first identified as
a region of homology between the Drosophila melan-
ogaster protein fork head and rat hepatocyte nuclear
factor 3 proteins (Weigel and Jackle 1990). Forkhead
domains are evolutionarily conserved and exist in a wide
range of species, from yeast to human (Kaufmann and
Knochel 1996). This DNA-binding motif is a variant of
the helix-turn-helix motif and consists of three a helices
and two large loops that form “wing” structures, hence
the name “winged-helix.”
FOXC1 (forkhead box [MIM 601090]) is a member
of this winged-helix family of transcription factors
(Larsson et al. 1995). Mutations in FOXC1 (formerly
known as “FREAC3” and “FKHL7”) underlie Axen-
feld-Rieger (AR) anterior eye-segment defects mapping
to chromosome 6p25 (Mears et al. 1998; Nishimura et
al. 1998; Mirzayans et al. 2000). Patients with AR mal-
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formations who have FOXC1mutations typically show
a spectrum of ocular findings, including iris hypoplasia,
a prominent Schwalbe line, iris adhesions, and gonio-
dysgenesis. The maldevelopment of the iridocorneal an-
gle, through which the aqueous humor must pass, can
result in increased intraocular pressure. Elevated intra-
ocular pressure increases the potential for atrophy of
the optic nerve and for retinal ganglion cell death,
thereby raising the risk of development of glaucoma.
These abnormalities in iridocorneal-angle development
are thought to arise from a defect in the migration and/
or differentiation of mesenchymal cells that contribute
to the anterior segment of the eye (Kume et al. 1998).
Patients with AR malformations who have FOXC1
mutations may also present with nonocular findings in-
cluding cardiac defects and dental dysgenesis (Swiderski
et al. 1999; Winnier et al. 1999; Mirzayans et al. 2000).
The systemic phenotypes suggest that FOXC1 has a
broad role in the developmental process. FOXC1 is ex-
pressed in fetal human tissues and is widely expressed
in adult human tissues (Pierrou et al. 1994; Mears et
al. 1998; Nishimura et al. 1998). The closely related
murine gene, Foxc1, is also expressed embryonically in
a wide range of tissues, including the periocular mes-
enchyme, cornea, and developing skeletal and organ
structures such as the heart and kidney (Hiemisch et al.
1998; Kume et al. 1998, 2000). Foxc1/ homozygous
mutant mice die at birth, with hydrocephalus and skel-
etal and eye defects, including an absent anterior cham-
ber and open or absent eyelids (Kume et al. 1998; Hong
et al. 1999; Kidson et al. 1999). Similar studies of
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Table 1
Statistics for Optimal Threads of Forkhead
Domain–Containing Proteins
Protein DGRFM
a ZRFM
b ERFM
FOXC1 102.16 5.28 31.06# 10
S82T 103.04 5.37 55.56# 10
I87M 100.58 5.23 31.56# 10
F112S 105.12 5.51 43.70# 10
I126M 99.02 5.15 35.39# 10
S131L 104.94 5.37 48.28# 10
Genesisc 95.69 5.03 39.43# 10
a Sums of contact potentials are expressed as DGRFM , the
energy associated with nonlocal, nonbonded interactions (Bry-
ant and Lawrence 1993).
b Z-scores, in SD units, represent the variance from the mean
of DGRFM.
c Statistics on Genesis represent the “self thread”—that is,
the alignment of the Genesis sequence against its own structure.
Foxc1/ heterozygotes have shown that thesemice have
anterior eye-segment defects similar to those found in
human patients with FOXC1 mutations, including iris
hypoplasia, a displaced Schwalbe line, and iridocorneal-
angle dysgenesis (Smith et al. 2000).
Two nonsense mutations and two deletions, all re-
sulting in frameshift mutations, have been reported in
FOXC1 (fig. 2A; Kume et al. 1998; Mears et al. 1998;
Nishimura et al. 1998; Mirzayans et al. 2000), pro-
ducing truncated products that are likely to be rapidly
degraded by cellular machinery. There also have been
five reported missense mutations of FOXC1 found in
patients with AR malformations (fig. 2A; Mears et al.
1998; Nishimura et al. 1998), which provide a valuable
tool for initiation of a functional dissection of FOXC1.
Missense mutations often modify the function of
a transcription factor; for example, PITX2 (MIM
601542) is a member of the paired bicoid family of
transcription factors and has been shown to underlie
anterior eye-segment defects mapping to chromosome
4q25 (Semina et al. 1996; Alward et al. 1998; Kulak et
al. 1998). Missense mutations reduce the ability of
PITX2 to bind DNA and to transactivate reporter genes,
with the severity of the defects corresponding to the
residual binding capacity of the PITX2 mutant proteins
(Kozlowski and Walter 2000). One of the missense mu-
tations of PITX2 has the additional effect of reducing
the localization of PITX2 to the nucleus. Similarly, in
Oct1 (MIM 602607), a POU-class transcription factor,
a single missense mutation can alter the protein-protein
interactions that are required for Oct1 to activate genes
(Lai et al. 1992). We therefore investigated the way in
which the naturally occurring missense mutations
within FOXC1 adversely affect FOXC1 structure and/
or function. We used molecular modeling, cell biology,
and biochemistry to assay the effects that missense mu-
tations of FOXC1 have on the ability of mutant FOXC1
proteins to adopt wild-type conformations, localize to
the nucleus, bind DNA, and activate gene expression.
Patients, Material, and Methods
Reports on Patients
All five families with FOXC1missense mutations pre-
sented with AR malformations. The clinical features of
these patients have been reported elsewhere (Mears et
al. 1998; Nishimura et al. 1998; Swiderski et al. 1999;
Winnier et al. 1999).
Threading Analysis
Threading experiments were performed by themethod
of Bryant and Lawrence (1993), with detailed deriva-
tions and methodology provided therein. Each query se-
quence was threaded through the atomic coordinates of
the solution structure of the forkhead domain, of the rat
forkhead protein Genesis, bound to its target DNA (Jin
et al. 1999). Five core segments (CS) were defined on
the basis of the nuclear magnetic resonance (NMR)
structure: CS1 spanned residues 10–20, CS2 spanned
residues 24–34, CS3 spanned residues 47–56, CS4
spanned residues 60–63, and CS5 spanned residues
73–97 (the numbering is based on the sequence of Gen-
esis [pdb:2HDC A], as presented in fig. 2B). For each
possible alignment, individual pairwise residue interac-
tions were determined on the basis of chemical type and
distance intervals, the tables for which have been pub-
lished by Bryant and Lawrence (1993). Through use of
these values, a conformational energy, DGRFM, defined
as the expected work required for substitution of a spe-
cific sequence R for a random sequence with the same
composition, in the context of folding-motifM, was then
calculated for each alignment (table 1). Z-scores (ZRFM)
and chance-occurrence probabilities (ERFM) were calcu-
lated to compare conformational energies for different
alignments. Chance-occurrence probabilities give the
odds that a random sequence of the same length and
amino acid composition would yield a threading energy
as low as the query sequence R. Calculations of energies
and of statistical significance were performed with C and
S-PLUS subroutines (Becker et al. 1988). Critical inter-
actions are defined as those having a pairwise residue
interaction energy !1 kcal/mol.
Plasmid Construction and Mutagenesis
FOXC1 cDNA (a gift from P. Carlsson) was repaired
at the 3′ end so that the FOXC1 cDNA encoded the entire
FOXC1 open reading frame. The FOXC1 cDNA was
subcloned into EcoRI–XbaI sites in the pcDNA4 His/
Max B plasmid (Invitrogen). The high G-C content of
FOXC1 precluded mutagenesis of the entire cDNA (data
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not shown), so an additional cloning step was required.
An ApaI–RsrII FOXCI fragment (fig. 2A) encompassing
the forkhead domain was cloned into pBluescript and
was mutagenized with the Quickchange mutagenesis
kit (Stratagene) and with appropriate primers, according
to the manufacturer’s protocol, with the addition of 5%
dimethyl sulfoxide. The resulting protein change, with
the nucleotide change in square brackets and the primer
sequences in parentheses, are as follows: S82T [G245C]
forward (5′-GGTGAAGCCGCCCTATACCTACATCG-
CGCTCATCACC-3′) and reverse (5′-GGTGATGAGC-
GCGATGTAGGTATAGGGCGGCTTCACC-3′); I87M
[C261G] forward (5′-GCTACATCGCGCTCATGA-
CCATGGCCATCCAG-3′) and reverse (5′-CTGGATG-
GCCATGGTCATGAGCGCGATGTAGC-3′); F112S
[T335C] forward (5′-CCAGTTCATCATGGACCGC-
TCCCCCTTCTACCGGG-3′) and reverse (5′-CCCGG-
TAGAAGGGGGAGCGGTCCATGATGAACTGG-3′);
I126M [C378G] forward (5′-GGCTGGCAGAACAGC-
ATGCGCCACAACCTCTCG-3′) and reverse (5′-CGA-
GAGGTTGTGGCGCATGCTGTTCTGCCAGCC-3′);
and S131L [C392T] forward (5′-CCGCCACAACCTC-
TTGCTCAACGAGTGCTTCG-3′) and reverse (5′-CG-
AAGCACTCGTTGAGCAAGAGGTTGTGGCGG-3′).
Potential mutant constructs were sequenced with an
automated sequencer (Li-COR). Subclones that were
confirmed to contain the required mutation were sub-
cloned back into the FOXC1 pcDNA His/Max vector,
and these final clones were sequenced.
Cell-Transfection and -Cotransfection Assays
One-hundred-millimeter plates of COS-7 cells grown
in Dulbecco’s modified Eagle’s medium and 10% fetal
bovine serum were transfected, at 80% confluency, with
2 mg of plasmid DNA, through use of FuGene6 trans-
fection reagent (Roche) according to the manufacturer’s
protocol. For FOXC1/Lac Z cotransfection assays, 1 mg
each of pcDNA4 His/Max Lac Z and of either pcDNA4
His/Max FOXC1 or pcDNA4 His/Max FOXC1 I87M
were cotransfected into COS-7 cells. After 48 h, proteins
were extracted and analyzed by western analysis.
Protein Extraction, Western Analysis, and
Immunofluorescence
Forty-eight hours after transfection, cells were washed
with PBS and were harvested by scraping. Cells were
pelleted; were resuspended in lysis buffer (20 mM HE-
PES pH 7.6, 150 mM NaCl, 0.5 mM DTT, 25% glyc-
erol, 2.5 mM phenylmethylsulfonyl fluoride, 10 mg of
Aprotinin/ml, 9 mg of Leupeptin/ml, and 10 mg of Pep-
statin A/ml) at 4C; and were lysed by gentle sonication
on ice. After centrifugation at 13,000 g for 5 min at 4C,
supernatants were transferred to a microfuge tube and
were resolved by SDS-PAGE. Western analysis and im-
munofluorescence were performed as described by Koz-
lowski and Walter (2000).
Northern Analysis
Forty-eight hours after transfection, COS-7 cells were
washed with PBS, and RNA was extracted through use
of TRIzol (Gibco/BRL) reagent. The RNA was size-sep-
arated on a 1# 3-(N-morpholino) propane sulfonic acid
pH 7.0, 0.66 M formaldehyde (BDH) agarose gel and
was transferred to Hybond (Amersham). The Hybond
blot was hybridized with [32P]-dCTP–labeled pcDNA4
His/Max B linearized with EcoRI. A second hybrid-
ization of the blot was performed with a [32P]-
dCTP–labeled PCR product from the 5′ FOXC1 (nucle-
otides 20–233). Control hybridization for loading
amounts was performed with [32P]-dCTP–labeled S26
ribosomal-protein RNA (Vincent et al. 1993).
Electrophoretic Mobility–Shift Assay (EMSA)
COS-7 cell extracts containing recombinant FOXC1
were equalized for amounts of recombinant FOXC1
protein, by western analysis. Reactions were brought up
to volume through use of untransfected COS-7 cell ex-
tract. Protein extracts were incubatedwith 1.3mMDTT,
5 mg of sheared salmon-sperm DNA, 1 mg of poly dIdC
(Sigma), and 10,000 cpm of [32P]-dCTP–labeled double-
stranded DNA containing the FOXC1-binding site
(forward, 5′-GATCCAAAGTAAATAAACAACAGA-3′;
and reverse, 5′-GATCTCTGTTGTTTATTTACTTT-
G-3′). Reactions were incubated at room temperature
for 15 min, after which 3 ml of 50% glycerol was added.
Six-percent polyacrylamide Tris-glycine-EDTA gels were
prerun for 15 min, and the products of the reactions
were subjected to electrophoresis at room temperature
for 50 min. Binding-specificity EMSAs were performed
as described above, with the addition of the [32P]-
dCTP–labeled double-stranded DNA oligonucleotides
listed in table 2.
Dual-Luciferase Assay
The dual-luciferase assay combines two reporter en-
zymes into an integrated, single-tube, dual-reporter as-
say format. The system provides sequential quantifica-
tion of both Photinus pyralis luciferase (reporter) and
Renilla reniformis luciferase (control) and takes advan-
tage of the luciferases’ different substrate requirements,
making it possible to differentiate between their respec-
tive bioluminescent reactions.
The cytomegalovirus promoter of pGL3 (Promega)
was replaced with a herpes simplex–virus thymidine ki-
nase (TK) promoter, from pRLTK (Promega), which was
cloned into the BglII-HindIII sites of pGL3. Six copies
of the FOXC1-binding sites (underlining indicates the
core, 9-bp FOXC1-binding site: forward, 5′-CTAGCCA-
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Table 2
The FOXC1 Binding Site and Variant Oligonucleotides
OLIGONUCLEOTIDE
SEQUENCEa
Forward Reverse
FOXC1 site GATCCAAAGTAAATAAACAACAGA GATCTCTGTTGTTTATTTACTTTG
Variant:
1 GATCCAAACTAAATAAACAACAGA GATCTCTGTTGTTTATTTAGTTTG
2 GATCCAAAGAAAATAAACAACAGA GATCTCTGTTGTTTATTTTCTTTG
3 GATCCAAAGTTAATAAACAACAGA GATCTCTGTTGTTTATTAACTTTG
4 GATCCAAAGTATATAAACAACAGA GATCTCTGTTGTTTATATACTTTG
5 GATCCAAAGTAATTAAACAACAGA GATCTCTGTTGTTTAATTACTTTG
6 GATCCAAAGTAAAAAAACAACAGA GATCTCTGTTGTTTTTTTACTTTG
7 GATCCAAAGTAAATTAACAACAGA GATCTCTGTTGTTAATTTACTTTG
8 GATCCAAAGTAAATATACAACAGA GATCTCTGTTGTATATTTACTTTG
9 GATCCAAAGTAAATAATCAACAGA GATCTCTGTTGATTATTTACTTTG
a The 9-bp core sequence of the in vitro–derived FOXC1 site (Pierrou et al. 1994) and of the variants
is underlined; the converted base in each oligonucleotide is shown in boldface italics. Purines were
converted to pyrimidines with an equivalent number of hydrogen bonds, and pyrimidines were converted
to purines with an equivalent number of hydrogen bonds.
AAGTAAATAAACAACAGCAAAGTAAATAAACAA-
CAGG-3′; and reverse, 5′-CTAGCCTGTTGTTTATTT-
ACTTTGCTGTTGTTTATTTACTTTGG-3′) were then
cloned into the EcoRI-NheI sites, 5′ to the TK promoter.
HeLa cells were then transfected with 50 ng of the pGL3
TK construct, 1 ng of the Renilla control vector, and
500 ng of a given FOXC1 pcDNA4 His/Max construct.
Transfected cells were grown for 48 h. The dual-lucif-
erase assays were performed with the Promega Dual Lu-
ciferase Assay kit, according to the manufacturer’s pro-
tocol (Promega). Reactions were replicated a minimum
of three times.
Results
Threading Experiments on the Forkhead Domain of
FOXC1
To study FOXC1 and understand the effects that mis-
sense mutations have on FOXC1 structure, molecular
models of the FOXC1 forkhead domain were generated
through use of threading algorithms developed by Bry-
ant and Lawrence (1993). Threading methods such as
the one employed here can be used to predict whether
a given protein sequence has the potential to adopt the
known three-dimensional structure of a wild-type pro-
tein. This computational technique identifies the align-
ments, between a query sequence and a given folding
motif, that are most likely to represent stable confor-
mational states, on the basis of implied pairwise and
hydrophobic interactions of residues that are nonlocal
in the sequence (Bryant and Lawrence 1993; Fetrow and
Bryant 1993).
The three-dimensional structure of the rat Genesis
protein bound with its target DNA (2HDC, chain A; Jin
et al. 1999) was used as a template for the threading
analysis of FOXC1. The positions of the a-helices in the
NMR structure of Genesis were used to define the core
segments within this motif. The core segments, there-
fore, represent the secondary-structural regions of the
protein and exclude most of the flexible regions. All
possible placements of the core segments along the query
sequence were considered in light of the constraints of
sequence length, core segment length, and limits of loop
length. Threading-contact energies were corrected for
sequence-composition bias, by random shuffling of the
aligned residues, to generate composition-corrected
threading scores (i.e., ZRFM). To evaluate the statistical
significance of computed threading scores, 100 random
permutations of the query sequence were generated, and
the alignment-optimization procedure was then repeated
on these now-shuffled sequences. On the basis of this
collection of scores, ERFM was calculated. The results
with the most favorable conformational energies (i.e.,
those with the lowest DGRFM values) were selected for
further study. A summary of the threading results is
shown in table 1. The calculated conformational ener-
gies of the “self-thread” of Genesis and FOXC1 are only
slightly different from one another (by ∼6 kcal/mol).
More important, the probability values (i.e., ERFM) for
both structures meet the statistical criteria of being.05
(5%), corresponding to 95% confidence in the threading
prediction. As such, it can be concluded that there is a
statistically significant alignment of the sequence of
FOXC1 with the structure of Genesis.
Figure 1A shows the energy scaffolds generated in this
threading experiment for the forkhead domain of
FOXC1. The energy scaffolds provide a method for vi-
sualization of the important intramolecular interactions
taking place within a protein. Here, the winged-helical
bundle can be seen to be held together by numerous
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Figure 1 A, Energy scaffolds for the forkhead domain of FOXC1. The a-carbon backbone of the protein is depicted as a curving “worm.”
Within the backbone, segments of the forkhead domain that comprise the core folding motifs are shown in blue, whereas the intervening loop
regions are shown in yellow. Helices and loop regions are as defined in figure 2B. Pairwise residue-interaction energies between core residues
(Bryant and Lawrence 1993) are shown by the width and coloring of the connected a-carbon positions on the protein backbone. Indicated
interactions are limited to those with pairwise residue-interaction energies 1 kcal/mol (“critical” pairwise interactions). Thick, magenta-
colored cylinders denote the most favorable interactions; cylinders of intermediate thickness denote interactions with lower, less-favorable
pairwise energies. Scaffolds were generated by the graphics program GRASP (Nicholls et al. 1991). The amino acid numbering corresponds to
that in the multiple-sequence alignment presented in figure 2B. The second view is 70 counterclockwise around the Y-axis, with respect to the
first view. B, Molecular model of the forkhead domain of FOXC1. A ribbon model of the backbone of FOXC1 is shown, with the side chains
of the mutated amino acid residues shown in a “ball-and-sticks” representation. The missense mutations in FOXC1 shown here are S82T at
the N-terminal end of helix 1, I87M in helix 1, F112S at the C-terminal end of helix 2, and I126M and S131L in helix 3. The numbering in
the figure corresponds to that of the human FOXC1 sequence.
hydrophobic interactions, represented by the thick, ma-
genta-colored cylinders. Several of the highly conserved,
large hydrophobic residues in this protein are involved
in the maintenance of these interactions within the hy-
drophobic core, which occur primarily between the con-
served residues at the helical interfaces. The energy scaf-
folds indicate that the most favorable hydrophobic
interactions observed in the threading model of the
FOXC1 forkhead domain involve Leu 86 and Ile 87 in
helix 1; Ile 104, Phe 107, and Ile 108 in helix 2; Ile 126
and Leu 130 in helix 3; and Phe 151 and Trp152 in the
last b-strand. The amino acid residues involved in these
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Figure 2 A, Schematic of the FOXC1 protein. The blackened rectangle represents the forkhead domain, and the missense mutations
studied are indicated above the forkhead domain. Mutations presented below the ideogram result in truncated products and were not tested.
Positions of restriction-enzyme sites used in subcloning are indicated above the ideogram. B, Multiple-sequence alignment of the forkhead
domain of human FOXC1 and related FOX proteins. The sequences shown in single-letter amino acid codes are those of human FOXC1
(AF048693), mouse Foxc1 (NM008592), human FOXC2 (Y08223), human FOXD1 (U13222), human FOXE1 (U89995), human FOXF1
(U13219), human FOXF2 (U13220), human HFH1 (AF153341), human FOXH1 (AF076292), mouse Foxh2 (AF110506), and rat Genesis/
Foxd3 (NM012183), respectively (NCBI Databases) . Amino acid residues showing absolute identity among these proteins are shown in white
against a blue background; those positions with conservative substitutions are shown against a yellow background. The positions of the a-
helices and b-strands, as defined in the NMR structure of Genesis, are schematically represented below the alignment. Positions of mutations
and corresponding amino acid changes in FOXC1 are indicated by the blackened arrowheads above the alignment. ALSCRIPT was used to
format the alignment.
critical pairwise interactions are conserved absolutely
between FOXC1 and Genesis.
To further assess the structural consequences of
FOXC1 mutations, threading analyses were performed
on all of the five missense mutations analyzed in this
study. All of these five missense mutations produced
threading scores similar to that of the wild-type FOXC1.
None of the mutations significantly altered any critical
pairwise residue interactions or destabilized the fork-
head domain of FOXC1 (table 1), suggesting that these
missense mutations do not significantly alter the struc-
ture of FOXC1. Since these missense mutations have
only subtle structural significance, the consequences that
these five mutations have on FOXC1 function were
investigated.
Expression of FOXC1
All five missense mutations occur within the forkhead
domain of FOXC1 (fig. 2A). COS-7 cells were trans-
fected with the vectors encoding wild-type and mutated
FOXC1. Whole-cell extracts of the transfected COS-7
cells were resolved by SDS-PAGE and immunoblot anal-
ysis. Detection of the N-terminal, vector-encoded,
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Figure 3 A, Western blot analysis of both recombinant FOXC1
and FOXC1 containing missense mutations. Transfected COS-7
whole-cell extracts were resolved by SDS-PAGE and by the N-terminal
Xpress epitope detected by immunoblotting with a mouse anti-Xpress
monoclonal antibody. B, Northern analysis of COS-7 extracts trans-
fected with FOXC1 pcDNA4 His/Max wild-type and missense mu-
tation constructs. [32P]-labeled EcoRI-linearized pcDNA4 His/Max
vector is hybridized to the Xpress epitope, detecting an appropriately
sized product at 4.4 kb. S26 cDNA was used as a loading control. C,
FOXC1 I87M, which reduces FOXC1 levels. COS-7 cells were tran-
siently cotransfected with LacZ pcDNA4 His/Max and either FOXC1
pcDNA4 His/Max or FOXC1 I87M pcDNA4 His/Max. Transfected
COS-7 whole-cell extracts were resolved by SDS-PAGE and by the N-
terminal Xpress epitope detected by immunoblotting. Only small
amounts (!5% of wild type) of the FOXC1 I87Mmutant protein were
detected.
Xpress epitope demonstrated a stable product, ∼65 kD
in size, for wild-type FOXC1 and for FOXC1 containing
four of the five missense mutations (fig. 3A). The fusion
proteins have the molecular weights expected from the
4-kD Xpress epitope and have the predicted 61-kD
FOXC1.
Reduced Protein Levels Resulting from the FOXC1
I87M Mutation
When cell extracts were made from COS-7 cells trans-
fected with the FOXC1 constructs, !5% of wild-type
amounts of the FOXC1 I87M mutant could be isolated.
To determine whether this problem with protein isola-
tion could be the result of a cryptic mutation in the
remainder of the FOXC1 pcDNA4 plasmid, five addi-
tional, different clones from independent mutagenesis
events of the I87M FOXC1 pcDNA4 His/Max were
transfected into COS-7 cells. All of these independent
FOXC1 I87M clones also produced !5% of wild-type
amounts of protein (data not shown). Northern analysis
was performed to test whether the FOXC1 cDNA con-
taining the I87M mutation was able to produce mRNA.
As seen in figure 3B, when mRNA is extracted from
COS-7 cells transfected with equivalent amounts of re-
combinant plasmid DNA, the amount of mRNA be-
tween the FOXC1 variants appears to be equal. To con-
firm that the FOXC1 I87M missense mutation reduced
the levels of FOXC1, LacZ pcDNA4 His/Max was co-
transfected in COS-7 cells with either I87M FOXC1 or
the wild-type FOXC1 construct, and protein was ex-
tracted. Both of the transfected COS-7 plates produced
b-galactosidase from the LacZ gene, indicating that the
cells were able to produce protein. However, the I87M
FOXC1 variant was present only in small amounts as
compared with wild-type FOXC1 (fig. 3C). It would
appear, therefore, that, while the I87M FOXC1 variant
is being introduced into cells, mRNA is being produced,
and the protein machinery of the cell is competent to
synthesize new proteins, FOXC1 containing the I87M
mutation nevertheless shows markedly reduced levels.
Localization of FOXC1 and Mutant Variants of FOXC1
to the Nuclei of COS-7 Cells
FOXC1 is a DNA-binding protein (Pierrou et al. 1994)
and, as such, should localize to the nucleus. To determine
where FOXC1 localized within cells, COS-7 cells were
transiently transfected with the FOXC1 expressionvector,
and immunofluorescence was performed against the vec-
tor-encoded Xpress epitope. Immunofluorescence against
the Xpress-tagged recombinant FOXC1 indicated that
FOXC1 is localized to the nucleus (fig. 4). The effects that
the missense mutations have on FOXC1 localizationwere
tested in a similar manner. COS-7 cells were transiently
transfected with the pcDNA4His/Max FOXC1missense-
mutation vectors. All FOXC1 proteins containing mis-
sense mutations were localized to the nuclei, demon-
strated by the colocalization of the Xpress epitope of the
recombinant FOXC1 proteins by DAPI staining of nuclei
(fig. 4). Interestingly, FOXC1 containing the I87M mu-
tation could still be localized to the cell nucleus by im-
munofluorescence. The immunofluorescent signal was
weaker and was present in a smaller percentage (!1%)
of cells within the visual field, compared with the signal
in the other missense mutations and in wild-type FOXC1
(fig. 4). This weak immunofluorescence is likely due to
the reduced levels of the FOXC1 I87M mutant protein.
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Figure 4 Immunofluorescence of Xpress epitope–tagged FOXC1 proteins. COS-7 cells were transiently transfected with the FOXC1
pcDNA4 His/Max constructs. In the upper six panels, the Xpress epitope–tagged recombinant FOXC1 proteins are localized to the nucleus,
indicated by Cy3 fluorescence. The lower six panels indicate the position of the nuclei, by staining with DAPI. Note that the Cy3 fluorescence
in the I87M transfection is weaker than it is in the other mutations.
As a result of the instability of this protein, the FOXC1
I87M mutation was not tested further.
EMSAs
EMSAs demonstrated that the FOXC1 forkhead do-
main preferentially forms DNA-protein complexes with
an in vitro–derived oligonucleotide, the FOXC1 site (ta-
ble 2; Pierrou et al. 1994). This oligonucleotide was used
in EMSA experiments to investigate whether FOXC1
missense mutations affect binding to the FOXC1 site.
The S82T missense mutation showed an approximately
three- to fivefold reduction in binding to the FOXC1
binding site when equal amounts of wild-type and S82T
FOXC1 protein were tested (fig. 5A). The S131L mu-
tation showed a more pronounced reduction in binding
to the FOXC1 binding site. At 20 times the amount of
protein, binding of the S131L mutant was still reduced
to levels well below that in wild-type FOXC1 (fig. 5A).
In contrast to the reduced binding capacity of the
FOXC1 S82T and S131L missense mutations, the
FOXC1 F112S and I126M missense mutants bound the
FOXC1 site at near–wild-type FOXC1-protein levels.The
affinity that the FOXC1 F112S mutation has for the
FOXC1 binding site is 1–2 times that of wild-type
FOXC1, whereas the binding capacity of FOXC1 I126M
is 0.5–1.0 times that of wild-type FOXC1 (fig. 5B).
Altered Binding Specificity of the FOXC1 I126M
Mutation
To determine whether the FOXC1missensemutations
altered the DNA-binding affinity of FOXC1, variant oli-
gonucleotides of the FOXC1 binding site were con-
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Figure 5 FOXC1 missense mutations that affect the DNA-bind-
ing ability of FOXC1. EMSA using the [32P]-labeled FOXC1 site was
incubated with FOXC1 wild-type and missense mutations containing
COS-7 protein extracts. Recombinant FOXC1 missense proteins were
equalized to recombinant wild-type FOXC1 by western blotting. The
position of the FOXC1-DNA complex is indicated by the blackened
arrowheads.A, FOXC1 containing the S82Tmissensemutation, show-
ing reduced affinity for the FOXC1 site. FOXC1 containing the S131L
missense mutations shows an ∼20-fold reduction in affinity for the
FOXC1 site. B, FOXC1 containing the F112S and I126M mutations,
showing DNA binding that is at wild-type or near–wild-type FOXC1-
protein levels.
structed (table 2). Of special interest were the FOXC1
F112S and I126M missense mutants, which bound to
the FOXC1 site at near–wild-type levels. EMSAs were
performed using the variant FOXC1 binding sites. The
FOXC1 F112S missense mutant showed an affinity for
the variant oligonucleotides that was equivalent to the
wild-type FOXC1 affinity for these nucleotides (fig. 6A
and D). The FOXC1 I126M mutant, however, did show
altered specificity compared with the wild-type FOXC1
protein. The affinity that FOXC1 I126M had for the
variant FOXC1 binding-site oligonucleotides 2 (altera-
tion of the core binding site is underlined; GAAAATAA-
A), 3 (GTTAATAAA), 8 (GTAAATATA), and 9 (GTA-
AATAAT) was higher than the affinity that the wild-type
FOXC1 protein had for these variant binding sites (fig.
6A and E). The affinity of FOXC1 I126M for variant
FOXC1 binding sites 2 and 9 was also higher than its
affinity for the FOXC1 site. FOXC1 S82T showed only
a weak affinity for oligonucleotides 1 and 2, whereas
the FOXC1 S131L mutant bound none of the variant
oligonucleotides (fig. 6B and C).
Transactivation Assays
FOXC1 is thought to act as a transcription factor;
therefore, the ability of FOXC1 to regulate expression
of a reporter gene was tested. The herpes simplex–virus
thymidine kinase (TK) promoter was positioned up-
stream of a luciferase reporter. HeLa cells were cotrans-
fected with the TK-luciferase reporter construct and ei-
ther pcDNA4 His/Max or FOXC1 pcDNA4 His/Max.
FOXC1 was found to stimulate transcription from the
TK promoter alone, showing luciferase activity to be
increased 5.3-fold over that in an empty vector control
(fig. 7A). The effect that the FOXC1 binding site had
on FOXC1 transactivation ability was then tested. Six
copies of the FOXC1 binding site were positioned up-
stream of the herpes simplex–virus TK promoter, again
used to activate transcription of a luciferase reporter.
When the FOXC1 binding sites were inserted upstream
of the TK promoter, activation of the luciferase gene by
FOXC1 was increased ∼12.5-fold over basal levels for
the TK promoter alone (fig. 7B). The effect that the
missense mutations had on FOXC1 function was then
tested. The FOXC1 S82T mutant showed luciferase ac-
tivity to be increased 7.1-fold (56.9% ofwild-type levels)
over basal levels, whereas the FOXC1 S131L mutant
showed no transactivation of the luciferase reporter
(7.4% of wild-type levels, compared with 8% for the
empty vector alone; fig. 7B). These transactivation re-
sults are in good agreement with the FOXC1 DNA-
binding studies.
Of particular interest were the FOXC1 F112S and
I126M mutants. Although these mutants did bind the
FOXC1 site at affinities similar to those of the wild-type
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Figure 6 Effect of FOXC1 missense mutations on DNA-binding specificity. EMSAs were performed with [32P]-labeled variant sites (see
table 2) incubated with COS-7 protein extracts containing either wild-type or mutant FOXC1. Recombinant proteins were equalized to wild-
type FOXC1 by western blotting. The position of the FOXC1-DNA complex is indicated by the blackened arrowheads. The FOXC1 I126M
protein shows an increased affinity for variant oligonucleotides 2, 3, 8, and 9, compared with wild-type FOXC1’s affinity for these oligonu-
cleotides. Also, compared with its affinity for the FOXC1 site, I126M shows an increased affinity for variant oligonucleotides 2 and 9.
FOXC1 protein (fig. 5B), the transactivation of these
mutants was severely reduced. The FOXC1 F112S mu-
tant was able to transactivate expression of luciferase at
only 11.7% of the level of wild-type activation. Simi-
larly, the FOXC1 I126M missense mutant was able to
transactivate expression of luciferase at only 17.3% of
wild-type FOXC1 levels. These data indicate that, al-
though the FOXC1 F112S and I126M mutant proteins
bind the FOXC1 binding site at near–wild-type levels,
their abilities to activate expression of a reporter gene
are markedly reduced.
Discussion
A three-dimensional structure of FOXC1 was modeled
on the basis of the resolved Genesis structure reported
by Jin et al. (1999). The model of the FOXC1 forkhead
domain was used to predict the effects that naturally
occurring missense mutations, identified in patients with
ocular phenotypes, would have on the structure of the
FOXC1 protein. Structural predictions were used in par-
allel with biochemical investigations of the molecular
consequences of these disease-causing alterations of
FOXC1. By comparing the structure, stability, nuclear
localization, DNA-binding capacity and specificity, and
transactivation potential, of wild-type versus mutant
FOXC1, we have elucidated the molecular defect un-
derlying each missense mutation.
The isoleucine residue at position 87 is located within
the first helix (fig. 1B) and is one of the main partici-
pants in the formation of the hydrophobic core. I87 is
involved in favorable hydrophobic interactions both
with I99, I104, and I108, in helix 2, and with I126,
L130, and L132, in helix 3 (fig. 1A). None of these
favorable hydrophobic interactions are disrupted by the
substitution, at position 87, of a methionine (a hydro-
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Figure 7 Disruption of the transactivation of a luciferase reporter construct, by FOXC1 missense mutations. The thick blackened bars
represent the mean of the values, and the Y error bar represents the SD of the values. In each panel, the upper bar, denoted by a minus sign
(), represents a vector-only control. In panel A, a schematic of the TK promoter–luciferase gene reporter construct is shown above the
histogram; transfected HeLa cells were assayed for luciferase activity, as described in the Patients, Material, and Methods section. In panel B,
a schematic of the FOXC1 site-TK promoter-luciferase gene reporter construct is shown above the histogram.
phobic amino acid) for the isoleucine. Although the
mechanisms underlying this reduced stability are un-
known, experimentally the FOXC1 I87M mutation re-
duces levels of FOXC1 protein (fig. 3). Protein insta-
bility may thus represent the mechanism by which the
I87M mutation of FOXC1 causes disease in patients.
The small amount of I87M FOXC1 that is detected by
immunofluorescence (fig. 4) and recovered in protein
extracts likely is due to the overexpression of the re-
combinant protein in the cell-culture system used here.
The FOXC1 S82T mutation occurs in a putative nu-
clear-localization signal (NLS) of the forkhead domain.
This region of the forkhead domain is proposed to be
part one of a bipartite NLS found within the forkhead
domain (Kaufmann and Knochel 1996) and thus could
interfere with proper nuclear localization of the protein.
Although the serine at amino acid 82 of the forkhead
domain is highly conserved throughout the forkhead
family, the presence of a threonine at this position does
occur naturally, albeit rarely, within the forkhead fam-
ily. FAST1 and Fast2 have a threonine instead of a serine
at amino acid 82, and both proteins function in a man-
ner consistent with nuclear localization (Labbe et al.
1998; Zhou et al. 1998; Yeo et al. 1999). In this light,
it is not surprising that the S82T change does not disrupt
the NLS and that the FOXC1 S82T protein correctly
localizes to the cell nucleus. In fact, in the present study,
all five missense mutants correctly localized to the cell
nuclei. Our data thus indicate that incorrect subcellular
localization of FOXC1 does not underlie impaired
FOXC1 function in the patients in whom these missense
mutations were found.
Themissense mutation S82T resides at theN-terminal
end of the first helix of FOXC1 (fig. 2B). The serine
residue at position 82 is located outside the hydrophobic
core, on the hydrophilic face of FOXC1. As expected,
substitution of this serine residue by a threonine residue
did not significantly change the threading scores, mean-
ing that the now-mutated sequence is still able to form
the predicted FOXC1 forkhead structure (table 1).
However, experimentally the S82Tmutant FOXC1 pro-
tein has a defect in DNA-binding capacity. To produce
wild-type levels of DNA binding, three to five times the
amount of FOXC1 S82T protein is required (fig. 5A),
in agreement with the reduction in transactivation (fig.
7B). This would indicate that the FOXC1 S82T mu-
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tation affects the DNA-binding capacity, not the trans-
activation capacity.
The serine residue at position 131, found in the third
helix, is on the hydrophilic face of the FOXC1 forkhead
model. Since this position is not involved in hydropho-
bic-core formation, substitution of a serine residue by
a leucine residue did not significantly alter the threading
scores shown in table 1. The mutated sequence still
shows a statistically significant match to its target struc-
ture. On the basis of its position within FOXC1, this
mutation is most likely involved in DNA binding. Ex-
perimentally, the S131L missense mutation markedly
reduces the ability of FOXC1 to bind the FOXC1 site
(fig. 5A), and this is consistent with the structural pre-
dictions. Therefore, the reduced affinities that both the
FOXC1 S82T and S131L mutant proteins have for the
FOXC1 binding site are likely to underlie impaired
FOXC1 function in patients with these mutations.
FOXC1 F112S and I126M missense mutants showed
near–wild-type FOXC1 levels in binding to the FOXC1
binding sites but showed severe reductions in transac-
tivation capacity. Previously, the FOXC1 forkhead do-
main had been thought to be responsible for nuclear
localization and DNA binding (Pierrou et al. 1994;
Mears et al. 1998; Nishimura et al. 1998). It is clear
from the experiments in the present study that amino
acid changes within the forkhead domain also can per-
turb the transactivation potential of FOXC1. These data
also indicate that, within the FOXC1 forkhead domain,
transactivation and DNA-binding capabilities are two
distinct and separable processes.
The loss of transactivation activity of the FOXC1
F112S and I126M mutant proteins may be attributable
to an inability to initiate transcription. In the l repres-
sor, a DNA-binding protein with a helix-turn-helix
structure like that of FOXC1, there are positive control
mutations that affect the activation ability but have no
effect on binding capacity (Guarente et al. 1982; Hoch-
schild et al. 1983). These missense mutations in the l
repressor affect the interaction between the l repressor
and RNA polymerase, rather than affecting the protein’s
interaction with DNA (Hawley and McClure 1983; Li
et al. 1994). The F112S and I126M missense mutations
in FOXC1 may represent positive control mutants in
the forkhead family of transcription factors.
On the basis of their position within the three-di-
mensional structure of the forkhead domain of FOXC1,
the F112S and I126M missense mutations of FOXC1
can be further distinguished from one another. The
F112S mutation is located outside the hydrophobic
core, in the loop region between helices 2 and 4 (fig.
1B). This position is not involved in hydrophobic-core
formation; hence, replacement at this position did not
interfere with the overall pattern of intermolecular in-
teractions. (It is important to note that this computa-
tional method takes into account only residues involved
in pairwise contacts with other residues. Thus, residues
with their side chains pointed outward presumably are
not involved in such interactions, and, therefore, the net
effect of mutations at these positions cannot be assessed
directly.) Biochemical studies showing that recombinant
F112S binds DNA as effectively as does the wild-type
protein—but that it does not transactivate reporter con-
structs that contain the sameDNA target sequence—can
be explained by the predicted location of this mutant
residue, away from the DNA-binding face of FOXC1.
The F112S mutation in FOXC1 most likely interferes
with protein-protein interactions that are necessary for
the transactivation of downstream genes.
The isoleucine at position 126 is within helix 3 and
is another important residue in the formation of the
hydrophobic core. The I126M mutation did not signif-
icantly change the threading scores in table 1, since the
substitution is by another similar hydrophobic amino
acid. The reduction in transactivation by recombinant
I126M probably is due to subtle changes in intermo-
lecular interactions, resulting in a more rigid molecule.
The I126M mutation may render FOXC1 unable to
alter the conformation of target DNA, thus preventing
transcription initiation.
The fact that the FOXC1 F112S and I126M mutant
proteins are able to bind to the FOXC1 binding site
indicates that the winged-helix structure that acts to
bind DNA sequences is fundamentally intact. Addition-
ally, the binding specificities that FOXC1 F112S and
I126M mutant proteins have with respect to the variant
oligonucleotides (fig. 6 and table 2) indicate that the
binding of these FOXC1 mutant proteins is sequence
specific. The NMR structural analyses of Jin et al.
(1999) predicted that helix 3 of forkhead proteins rec-
ognizes the major groove of the DNA, implicating this
region of the protein in DNA-site recognition. Our ex-
perimental data, demonstrating that the I126M muta-
tion in helix 3 of FOXC1 results in a mutant protein
with altered DNA-site preference, are in excellent agree-
ment with this prediction.
In the mouse mutant dysgenic lens (dyl), Foxe3, the
gene responsible for the dyl phenotype, has two mis-
sense mutations, F93L and F98S, both in the forkhead
domain. The F112S mutation of FOXC1 corresponds
to the same position in the forkhead domain as does
the F98S mutation found in dyl mice (Blixt et al. 2000).
In both cases, the phenylalanine is replaced by a serine.
The dyl mutation, like the F112S mutation of FOXC1,
may therefore result in an inability of Foxe3 to trans-
activate genes required for proper lens formation. The
F93L substitution, also found in the dyl allele of Foxe3,
may also exert an effect in addition to the effect of the
F98S substitution.
Data from patients with FOXC1 mutations (Mears
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et al. 1998; Nishimura et al. 1998), as well as data from
mouse models with Foxc1 alterations (Kume et al. 1998;
Mears et al. 1998; Kidson et al. 1999; Smith et al. 2000),
present strong evidence for a haploinsufficiency model
for FOXC1. In mice, a null-heterozygous mutation of
Foxc1 results in anterior-segment defects of the eye, sim-
ilar to those found in patients with AR malformations.
In humans, missense mutations that still produce full-
length FOXC1 with reduced activity cannot be distin-
guished, at a phenotypic level, from null or nonsense
mutations. The S82T FOXC1 missense mutation pro-
vides strong evidence for a model of haploinsufficiency
for FOXC1. The S82T missense mutation shows almost
60% of wild-type transactivation activity, yet the phe-
notypic consequences are the same as those in patients
with the I87M mutation, which produces !5% of wild-
type amounts of FOXC1-protein. In fact, the ocular
phenotypic differences between patients with any of the
missense mutations were the same as the ocular phe-
notypic differences between patients with the same mis-
sense mutations. Within a family with a given missense
mutation of FOXC1, there is often a spectrum of phe-
notypic consequences (Mears et al. 1998; Nishimura et
al. 1998).
Although the penetrance of FOXC1 defects within
the eye is high (Mears et al. 1998; Nishimura et al.
1998), there are likely to be environmental factors and/
or modifier genes that result in variable expressivity.
Phenotypic variability could reflect a level of chance in
developmental events, which is related to the timing,
location, and level of expression of developmentally im-
portant downstream targets of FOXC1. Regulation of
FOXC1 levels is therefore critical for proper develop-
ment. A recent report by other researchers indicates that
individuals with three copies of FOXC1 show anterior
eye-segment defects (Lehmann et al. 2000). This report,
combined with the present study’s data on partial ac-
tivity of one of the FOXC1 missense mutations, lead
us to conclude that the regulation of FOXC1 levels is
extremely stringent, with 178% of wild-type levels (nor-
mal allele activity plus FOXC1 S82T activity) but
!150% of wild-type levels (activity of three alleles) of
FOXC1 being required for correct FOXC1 function.
Mutations in FOXC1 and PITX2 result in similar
ocular phenotypes. Although genotype-phenotype cor-
relations have been established for defects in PITX2
(Kozlowski and Walter 2000), it appears that no such
relationship can be established for FOXC1. Mutant
PITX2 proteins that retain partial function result in an-
terior eye-segment defects that are milder than those
found in patients with no PITX2 function, but this
clearly is not the case for FOXC1. Aberrant ocular de-
velopment arising from PITX2 mutations may follow a
mechanism/pathway different than that of ocular de-
fects arising from FOXC1 mutations.
The upstream elements and downstream targets of
FOXC1 remain unknown. Possible target genes include
those involved in cellular processes such as cell-cell ad-
hesion, cell migration, and cell differentiation (Kume et
al. 1998; Smith et al. 2000). Tight regulation of FOXC1,
possibly within the aforementioned cellular pathways,
appears to be critical for normal eye development.
Note added in proof.—A very recent study by Nish-
imura et al. (2001) found an additional eight novel mu-
tations: one missense mutation, five frameshift muta-
tions, and two duplications.
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